Drug Res (Stuttg) 2019; 69(11): 630-638
DOI: 10.1055/a-0975-9124
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Influence of Silybum Marianum on Morphine Addicted Rats, Biochemical Parameters and Molecular Simulation Studies on µ-Opioid Receptor

Rahime Eshaghi Malekshah
1   Department of Chemistry, Semnan University, Semnan, Iran
,
Ali Khaleghian
2   Biochemistry Department, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran
› Author Affiliations
Further Information

Publication History

received 06 February 2019

accepted 05 July 2019

Publication Date:
13 August 2019 (online)

Abstract

The present study aimed to investigate effects of medicinal plant (Silybum marianum) on the animals with treatment of morphine addiction compared to chemical drug (Naloxane). Also, this study was conducted to evaluate the role of Silybum marianum on factors of serum ALT, AST activities and activity of the antioxidant enzyme:superoxide dismutase (SOD) as well as the extent of lipid peroxidation of Morphine addicted rats.High performance liquid chromatography (HPLC) has been used to measure Morphine in the serum, enzymes functions well as lipid peroxidation of Morphine addicted animals. Results demonstrate treatment with S. Marianum for opium rats at dose 400 mg/kg led to a major reduction in serum morphine compared to Naloxane (400 mg/kg>200 mg/kg>100 mg/kg>Naloxane. The positive effect of dose-dependence on liver enzymes function (ALT and AST) in order of 400 mg/kg>Naloxane>200 mg/kg>100 mg/kg. Furthermore, the findings show that the malondialdehyde levels are increased in opium-treated animals. However, the extracts also demonstrate a significant reduction in the MDA levels compared to the control, 400 mg/kg>200 mg/kg>Naloxane>100 mg/kg. Increase of Silybum marianum extract in rats pretreated significantly elevated the activities of superoxide dismutase (SOD).At last, our data suggest that Silibinin as the main component found in Milk thistle is more selective toward µ-Opioid Receptor than Morphine and Naloxane as a narcotic receptor antagonist.

Supplementary Material

 
  • References

  • 1 Elhaak MA, Ebrahim M KH. Elshintinawy et al. Original research article allelopathic potential of silybum marianum and its utilization ability as a bio herbicide. Int J Curr Microbiol App Sci. 2014; 3: 389-401
  • 2 Dhawan K, Kumar KS, Sharma A. Reversal of morphine tolerance and dependence by passiflora incarnata-a traditional medicine to combat morphine addiction. Pharm Biol 2002; 40: 576-580
  • 3 Saller R, Meier R, Brignoli R. The use of silymarin in the treatment of liver diseases. Drugs. 2001; 61: 2035-2063
  • 4 Sh Javed, Kohli K, Ali M. Reassessing bioavailability of silymarin. Altern Med Rev 2011; 16: 239-249
  • 5 Flora K, Hahn M, Rosen H. et al. Milk thistle (silybum marianum) for the therapy of liver disease. Am J Gastroenterol 1998; 93: 139-143
  • 6 Gordon A, Hobbs DA, Bowden DS. et al. Effects of silybum marianum on serum hepatitis c virus rna, alanine aminotransferase levels and well-being in patients with chronic hepatitis c. J Gastroenterol Hepatol 2006; 21: 275-280
  • 7 Lu P, Mamiya T, Lu LL. et al. Silibinin attenuates amyloid Β25–35 peptide-induced memory impairments: Implication of inducible nitric-oxide synthase and tumor necrosis factor-α in Mice. J Pharmacol Exp Ther 2009; 331: 319-26.
  • 8 Tota S, Kamat PK, Shukla R. et al. Improvement of brain energy metabolism and cholinergic functions contributes to the beneficial effects of silibinin against streptozotocin induced memory impairment. Behav Brain Res 2011; 221: 207-215
  • 9 Singh D, Murugaiyah V. Hamid et al. Assessment of gonadotropins and testosterone hormone levels in regular mitragyna speciosa (Korth.) Users. J Ethnopharmacol 2018; 221: 30-36
  • 10 Post-White J, Ladas EJ, Kelly KM. Advances in the use of milk thistle (Silybum Marianum). Integr Cancer Ther 2007; 6: 104-109
  • 11 Boigk G, Stroedter GL, Herbst H. et al. Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats. Hepatol 1997; 26: 643-649
  • 12 Tang YL, Zhao D, Zhao Ch. et al. Opiate addiction in China: Current situation and treatments. Addiction 2006; 101: 657-65.
  • 13 Ebrahimie M, Bahmani M, Shirzad H. et al. Review study on the effect of iranian herbal medicines on opioid withdrawal syndrome. JEBIM 2015; 20: 1-8
  • 14 Malekshah RE, Mahjub R, Rastgarpanah M. et al. Effect of zeolite nano-materials and artichoke (Cynara Scolymus L) leaf extract on increase in urinary clearance of systematically absorbed nicotine. Arzneimittel-Forschung/Drug Research 2012; 62: 650-654
  • 15 Mattioli L, Titomanlio F, Perfumi M. Effects of a Rhodiola Rosea L. Extract on the acquisition, expression, extinction, and reinstatement of morphine-induced conditioned place preference in mice. Psychopharmacology 2012; 221: 183-193
  • 16 Shi J, Liu Y, Fang YX. et al. Traditional Chinese medicine in treatment of opiate addiction. Acta Pharmacologica Sinica 2006; 27: 1303-1308
  • 17 Sean G, Mikael F, John M. et al. Effect of commercial silybum marianum (L.) Gaertn. (Milk Thistle) Capsules on CCL4-induced male albino rats, Int J Curr Sci. 2014; 12: 103-109
  • 18 Habán M, Habánová M, Otepka P. et al. Milk thistle (silybum marianum [l .] Gaertn .) Cultivated in polyfunctional crop rotation and its evaluation. Research J. Agric Sci 2010; 42: 111-117
  • 19 Sobczak M, Sałaga M, Storr MA. Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: Current concepts and future perspectives. J Gastroenterol. 2014; 49: 24-45
  • 20 Arulmozhi V, Pandian K, Mirunalini S. Ellagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB). Colloids Surf. 2013; 110: 313-320
  • 21 Atici S, Cinel I, Cinel L. et al. Liver and kidney toxicity in chronic use of opioids: An experimental long term treatment model. J. Biosci 2005; 30: 245-252
  • 22 Rasool M, Iqbal J, Malik A. et al. Hepatoprotective effects of silybum marianum (silymarin) and glycyrrhiza glabra (glycyrrhizin) in combination: A possible synergy. J Evid Based Complementary Altern Med 2014; 2014: 641597
  • 23 Cacciapuoti F, Scognamiglio A, Palumbo R. et al. Silymarin in non alcoholic fatty liver disease.” World Journal of World J Hepatol 2013; 5: 109-113
  • 24 Atiba AS, Abbiyesuku FM, Oparinde DP. et al. Plasma Malondialdehyde (MDA): An indication of liver damage in women with pre-eclamsia. Ethiop J Health Sci 2016; 26: 479-486
  • 25 Aghazadeh S, Amini R, Yazdanparast R. et al. Anti-apoptotic and anti-inflammatory effects of silybum marianum in treatment of experimental steatohepatitis. Exp Toxicol Pathol 2011; 63: 569-74.
  • 26 Ayala A, Muñoz MF, Argüelles S. Lipid peroxidation: Production, metabolism, and signaling mechanisms of malondialdehyde and 4-Hydroxy-2-Nonenal. Oxid Med Cell Longev. 2014; 2014: 360438
  • 27 Noorani AA, Kale Mo K. Pretreatment of albino rats with methanolic fruit extract of randia dumetorum (l.) protects against alcohol induced liver damage. Korean J Physiol Pharmacol 2012; 16: 125-130
  • 28 Akkaya H, Yilmaz O. Antioxidant capacity and radical scavenging activity of silybum marianum and ceratonia siliqua. Ekoloji. 2012; 21: 9-16
  • 29 Solhi H, Ghahremani R, Kazemifar AM. et al. Silymarin in treatment of non-alcoholic steatohepatitis: A randomized clinical trial. Caspian J Intern Med 2014; 5: 9-12
  • 30 Cetinkunar S, Tokgoz S, Bilgin BC. et al. The effect of silymarin on hepatic regeneration after partial hepatectomy: Is silymarin effective in hepatic regeneration. Int J Clin Exp Med 2015; 8: 2578-2585